Sezioni | |
---|---|
Oncologia Medica |
Titolo | Autori | Anno |
---|---|---|
NF-κB as a target for pancreatic cancer therapy. | Carbone, C.; Melisi, Davide | 2012 |
Pancreatic Cancer: between bench and bedside. | D. Melisi;A. Budillon | 2012 |
Anti-VEGF treatment-resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype. | Carbone, C.; Moccia, T.; Zhu, C.; Paradiso, G.; Budillon, A.; Chiao, P. J.; Abbruzzese, J. L.; Melisi, Davide | 2011 |
Emerging pathways and future targets for the molecular therapy of pancreatic cancer. | Vaccaro, V; Melisi, Davide; Bria, Emilio; Cuppone, F; Ciuffreda, L; Pino, Ms; Gelibter, A; Tortora, Giampaolo; Cognetti, F; Milella, M. | 2011 |
Modulation of pancreatic cancer chemoresistance by inhibition of TAK1. | Melisi, Davide; Xia, Q.; Paradiso, G.; Ling, J.; Moccia, T.; Carbone, C.; Budillon, A.; Abbruzzese, J. L.; Chiao, P. J. | 2011 |
Piazzale Ludovico Antonio Scuro 10
37124 Verona
Partita IVA
01541040232
Codice Fiscale
93009870234
© 2022 | Università degli studi di Verona | Credits